Literature DB >> 24605033

Screening and early detection of pancreatic cancer in high risk population.

Ming-Chu Chang1, Jau-Min Wong1, Yu-Ting Chang1.   

Abstract

Pancreatic cancer is a serious growing health issue in developed countries. For patients diagnosed with pancreatic cancer, the five year survival rate is below 5%. One major important reason leads to the poor survival rate is lack of early detection of pancreatic cancer. Over 80% of the patients are diagnosed in advanced disease stages. Screening for pancreatic cancer is a desirable option for high risk individuals to allow early detection and treatment of curable pancreatic neoplasms at a pre-invasive stage. This article highlights the need, endpoint, population, method, diagnostic yield, and the problems of current screening programs.

Entities:  

Keywords:  High risk population; Pancreatic cancer screening; Pancreatic neoplasm; Peutz-Jeghers syndrome

Mesh:

Year:  2014        PMID: 24605033      PMCID: PMC3942839          DOI: 10.3748/wjg.v20.i9.2358

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  58 in total

1.  Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis.

Authors:  Jordan M Winter; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; David Chang; Taylor S Riall; Joann Coleman; Patricia K Sauter; Marcia Canto; Ralph H Hruban; Richard D Schulick; Michael A Choti; Charles J Yeo
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment.

Authors:  C D Ulrich
Journal:  Pancreatology       Date:  2001       Impact factor: 3.996

3.  Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Authors:  Marcia Irene Canto; Michael Goggins; Ralph H Hruban; Gloria M Petersen; Francis M Giardiello; Charles Yeo; Elliott K Fishman; Kieran Brune; Jennifer Axilbund; Constance Griffin; Syed Ali; Jeffrey Richman; Sanjay Jagannath; Sergey V Kantsevoy; Anthony N Kalloo
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

4.  Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; D C Whitcomb
Journal:  Med Clin North Am       Date:  2000-05       Impact factor: 5.456

5.  Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

Authors:  Wigdan Al-Sukhni; Ayelet Borgida; Heidi Rothenmund; Spring Holter; Kara Semotiuk; Robert Grant; Stephanie Wilson; Malcolm Moore; Steven Narod; Kartik Jhaveri; Masoom A Haider; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2011-11-30       Impact factor: 3.452

6.  Very high risk of cancer in familial Peutz-Jeghers syndrome.

Authors:  F M Giardiello; J D Brensinger; A C Tersmette; S N Goodman; G M Petersen; S V Booker; M Cruz-Correa; J A Offerhaus
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

8.  Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Authors:  Marcia S Brose; Timothy R Rebbeck; Kathleen A Calzone; Jill E Stopfer; Katherine L Nathanson; Barbara L Weber
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

Review 9.  Inherited pancreatic cancer: surveillance and treatment strategies for affected families.

Authors:  S J Rulyak; T A Brentnall
Journal:  Pancreatology       Date:  2001       Impact factor: 3.996

Review 10.  Hereditary pancreatic cancer.

Authors:  H T Lynch; R E Brand; C A Deters; T G Shaw; J F Lynch
Journal:  Pancreatology       Date:  2001       Impact factor: 3.996

View more
  18 in total

1.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

2.  Dietary food groups intake and cooking methods associations with pancreatic cancer: a case-control study.

Authors:  Zeinab Ghorbani; Azita Hekmatdoost; Hassan Eini Zinab; Solmaz Farrokhzad; Roya Rahimi; Reza Malekzadeh; Akram Pourshams
Journal:  Indian J Gastroenterol       Date:  2015-06-12

3.  Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan.

Authors:  Ming-Chu Chang; Chih-Horng Wu; Shih-Hung Yang; Po-Chin Liang; Bang-Bin Chen; I-Shiow Jan; Yu-Ting Chang; Yung-Ming Jeng
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

4.  Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine.

Authors:  Xin Fan; Zhengfa Mao; Xiaoyan Ma; Lei Cui; Jianguo Qu; Lihui Lv; ShengChun Dang; Xuqing Wang; Jianxin Zhang
Journal:  Tumour Biol       Date:  2015-09-10

5.  Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.

Authors:  Carrie X Cao; Jeremy M Sharib; Amie M Blanco; Dena Goldberg; Paige Bracci; Rita A Mukhtar; Laura J Esserman; Kimberly S Kirkwood
Journal:  J Am Coll Surg       Date:  2019-10-28       Impact factor: 6.113

6.  In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.

Authors:  Fang Liu; Wenjun Le; Tianxiao Mei; Tiegong Wang; Luguang Chen; Yi Lei; Shaobin Cui; Bingdi Chen; Zheng Cui; Chengwei Shao
Journal:  Int J Nanomedicine       Date:  2016-05-19

7.  Differentially regulated ADAMTS1, 8, 9, and 18 in pancreas adenocarcinoma.

Authors:  Murat Özgür Kılıç; Büşra Aynekin; Mikdat Bozer; Adem Kara; Hacer Haltaş; Duygu İçen; Kadir Demircan
Journal:  Prz Gastroenterol       Date:  2017-12-14

8.  Pilot study of rapid MR pancreas screening for patients with BRCA mutation.

Authors:  Giuseppe Corrias; Mitchell C Raeside; Andrea Agostini; Sandra Huicochea-Castellanos; David Aramburu-Nunez; Ramesh Paudyal; Amita Shukla-Dave; Olga Smelianskaia; Marinela Capanu; Junting Zheng; Maggie Fung; David P Kelsen; Debra A Mangino; Mark E Robson; Deborah J Goldfrank; Jean Carter; Peter J Allen; Bettina Conti; Serena Monti; Richard K G Do; Lorenzo Mannelli
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

9.  Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.

Authors:  Kazufumi Honda; Michimoto Kobayashi; Takuji Okusaka; Jo Ann Rinaudo; Ying Huang; Tracey Marsh; Mitsuaki Sanada; Yoshiyuki Sasajima; Shoji Nakamori; Masashi Shimahara; Takaaki Ueno; Akihiko Tsuchida; Naohiro Sata; Tatsuya Ioka; Yohichi Yasunami; Tomoo Kosuge; Nami Miura; Masahiro Kamita; Takako Sakamoto; Hirokazu Shoji; Giman Jung; Sudhir Srivastava; Tesshi Yamada
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

10.  Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.

Authors:  Toshihiro Yoneyama; Sumio Ohtsuki; Kazufumi Honda; Makoto Kobayashi; Motoki Iwasaki; Yasuo Uchida; Takuji Okusaka; Shoji Nakamori; Masashi Shimahara; Takaaki Ueno; Akihiko Tsuchida; Naohiro Sata; Tatsuya Ioka; Yohichi Yasunami; Tomoo Kosuge; Takashi Kaneda; Takao Kato; Kazuhiro Yagihara; Shigeyuki Fujita; Wilber Huang; Tesshi Yamada; Masanori Tachikawa; Tetsuya Terasaki
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.